Bimzelx (bimekizumab-bkzx) — Highmark
Psoriatic Arthritis (PsA) – without spinal or axial disease
Initial criteria
- age ≥ 18 years
- diagnosis of PsA without spinal disease
- prescribed by or in consultation with a rheumatologist or dermatologist
- therapeutic failure or intolerance to at least one non-biologic DMARD or all non-biologic DMARDs are contraindicated
- therapeutic failure or intolerance to at least one step 1 plan-preferred agent for PsA
Reauthorization criteria
- disease stability or beneficial response to therapy